[HTML][HTML] A review on CXCR4/CXCL12 axis in oncology: no place to hide

…, WB Nagengast, H Timmer-Bosscha… - European journal of …, 2013 - Elsevier
Classical chemotherapeutic anti-cancer treatments induce cell death through DNA damage
by taking advantage of the proliferative behaviour of cancer cells. The more recent approach …

Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds

C Meijer, NH Mulder, H Timmer-Bosscha, WJ Sluiter… - Cancer research, 1992 - AACR
The role of glutathione (GSH) in the effectiveness of and resistance to 7 platinum compounds
(5 Pt(II) and 2 Pt(IV) drugs] was evaluated in a 8.6-fold cisplatin (CDDP)-resistant human …

[HTML][HTML] ATP-binding cassette (ABC) transporters in normal and pathological lung

…, W Timens, RJ Scheper, H Timmer-Bosscha… - Respiratory …, 2005 - Springer
ATP-binding cassette (ABC) transporters are a family of transmembrane proteins that can
transport a wide variety of substrates across biological membranes in an energy-dependent …

[HTML][HTML] Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer

…, A Di Pietro, H Timmer-Bosscha… - The Journal of …, 2010 - Am Soc Clin Investig
Platinum-based chemotherapies such as cisplatin are used as first-line treatment for many
cancers. Although there is often a high initial responsiveness, the majority of patients …

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy

UM Domanska, H Timmer-Bosscha, WB Nagengast… - Neoplasia, 2012 - Elsevier
Several in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in
tumor-stroma interactions. Stromal cells present in the tumor microenvironment express high …

89Zr-bevacizumab PET imaging in primary breast cancer

…, RG Pleijhuis, H Timmer-Bosscha… - Journal of nuclear …, 2013 - Soc Nuclear Med
Vascular endothelial growth factor (VEGF)-A is overexpressed in most malignant and
premalignant breast lesions. VEGF-A can be visualized noninvasively with PET imaging and using …

[HTML][HTML] Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in …

…, S Daum, S Salcher, A Noureen, H Timmer-Bosscha… - Molecular Cancer, 2022 - Springer
Background Crosstalk between neoplastic and stromal cells fosters prostate cancer (PCa)
progression and dissemination. Insight in cell-to-cell communication networks provides new …

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922

…, THO Munnink, H Timmer-Bosscha… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Angiogenesis is a critical step in tumor development, in which vascular endothelial growth
factor (VEGF) is a key growth aspect. Heat shock protein 90 (HSP90), a molecular chaperone, …

Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake

…, JA Gietema, ET Garbacik, H Timmer-Bosscha… - Cancer research, 2013 - AACR
In solid tumors, angiogenesis occurs in the setting of a defective vasculature and impaired
lymphatic drainage that is associated with increased vascular permeability and enhanced …

89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

…, WB Nagengast, H Timmer-Bosscha… - European Journal of …, 2010 - Elsevier
NVP-AUY922, a potent heat shock protein (HSP) 90 inhibitor, downregulates the expression
of many oncogenic proteins, including the human epidermal growth factor receptor-2 (HER2…